Back to the main directory
EarningsReview / Equity
- Risk of a WuSu slowdown by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- Sustainability Weekly 3–7 July 2023 by Oddo BHF
- Actinogen Medical - Refining the upcoming XanaMIA Phase IIb study by Edison Investment Research
- New SRI label: the art of reconciling exclusions and transitions by Oddo BHF
- China Sporting Goods: June Gloom by BNP Paribas Exane
- Taiwan Petrochemicals by HSBC
- BW LPG (Buy, TP: NOK148.00) - Upside potential on strong markets by DnB Markets
- Tokmanni (Buy, TP: EUR15.00) - A well-spent dollar by DnB Markets
- Wihlborgs (Buy, TP: SEK90.00) - Business as usual by DnB Markets
- The catalysts from here by BNP Paribas Exane
- Good Times, Bad Times, Better Times by BNP Paribas Exane
- FQ2''23 preview: Finding the bottom by BNP Paribas Exane
- Safe Group - CA S1 2023 by MidCap Partners
- Safe Group - H1 2023 Revenue by MidCap Partners
- Downside risk to consensus priced in, waiting for a catalyst by BNP Paribas Exane
- Chemicals: where they go - must we follow? by BNP Paribas Exane
- MSFT in a good position to close the ATVI acquisition soon by BNP Paribas Exane
- Trelleborg (Buy, TP: SEK320.00) - Attractive valuation and exposure by DnB Markets
- Resurs Holding (Hold, TP: SEK22.00) - Set for further margin pressure and loan losses by DnB Markets
- Protector (Buy, TP: NOK213.00) - Strong growth momentum by DnB Markets
- Itaú BBA on América Móvil: Positive – Earnings Beat, Even Excluding FX Gains by Itau
- What now, green growth machines? by BNP Paribas Exane
- 2Q/1H23: Geographical mix still in their favour by BNP Paribas Exane
- Tryg - Now the cat is out of the bag by Danske Bank Equity Research
- 2Q23 preview: sequential improvement but provisional pricing headwinds by BNP Paribas Exane
- Sustainability Weekly 3 – 7 Juillet 2023 by Oddo BHF
- Fabege - Hold: An appealing value case, but no triggers by Nordea
- Nouveau label ISR : de l’art de concilier exclusions et transitions by Oddo BHF
- Profit warning on Q2 and FY by BNP Paribas Exane
- Wihlborgs - Lifting its surplus ratio by Danske Bank Equity Research
- Avance Gas (Hold, TP: NOK96.00) - FFAs suggest upside potential by DnB Markets
- Dorian LPG (Hold, TP: USD26.90) - Balanced risk/reward by DnB Markets
- Paradox Interactive AB (Hold, TP: SEK280.00) - Niche game portfolio bearing fruit by DnB Markets
- TGS (Buy, TP: NOK200.00) - Multi-client expectations lowered by DnB Markets
- H1 preview: assessing flow concerns by BNP Paribas Exane
- Defensive, discounted, and with a few tailwinds by BNP Paribas Exane
- AMS (AMS LN) by HSBC
- Wihlborgs - Buy/SEK 97: Good operational momentum and ATH NOI in Q2 by Nordea
- Warning and potash curtailments by BNP Paribas Exane
- Recce Pharmaceuticals - Gearing up for more R327 studies by Edison Investment Research
- Q2 preview: car rental demand to remain strong by BNP Paribas Exane
- Pre-Close Call Feedback (F1Q24) by BNP Paribas Exane
- Valmet (Buy, TP: EUR36.00) - Substantial softening priced in by DnB Markets
- Tryg (Buy, TP: DKK185.00) - Feeling the impact of FX by DnB Markets
- PGS (Hold, TP: NOK6.00) - Better risk/reward, still fairly valued by DnB Markets
- GenAI: Capgemini''s Friend or Foe? by BNP Paribas Exane
- Originate, build, sell and repeat by BNP Paribas Exane
- Release of the labour pressure cooker? by BNP Paribas Exane
- Industrivärden - Potential for continued outperformance; keep Buy by Danske Bank Equity Research